Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.
Edesa Biotech (NASDAQ:EDSA – Free Report) had its price target lowered by HC Wainwright from $70.00 to $21.00 in a research report report published on Wednesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Edesa Biotech’s Q4 2023 earnings at ($0.73) EPS, FY2023 earnings at […]
Edesa Biotech (NASDAQ:EDSA) PT Lowered to $21.00 at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.